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Stem cellThe octamer-binding transcription factor 4 (Oct4) is essential for maintaining the self-renewal and
pluripotency of embryonic stem cells (ESCs). Post-translational modiﬁcations (PTMs) of Oct4 critically
control its structure, function and intracellular localization. However, determination of Oct4 PTM proﬁles
has largely been restricted by the quantity and purity of the Oct4 protein samples required for mass
spectrometric analyses. In this study, by incubating the Escherichia coli-derived His-tagged Oct4 proteins
with the whole cell lysates of a variety of human cells followed by retrieving the reacted Oct4 proteins
with the Ni–NTA beads, we developed a labor- and cost-effective in vitro PTM method that allowed for
mass spectrometric determination of the phosphorylation proﬁles of Oct4 proteins exposed to various
cell-free systems. A number of Oct4 phosphorylation sites that were commonly present in all the cell-free
systems or speciﬁcally present in a particular cellular context were identiﬁed, indicating that Oct4 is con-
trolled by both common and distinct PTM regulatory pathways. Our work provided a proof-of-concept
that such a cell-free system-based in vitro PTM approach can be applied to systematically map out the
physiologically-relevant PTM sites in Oct4 proteins, which opened up an avenue to fully decipher the
Oct4 PTM barcodes in various cellular contexts.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction regulatory mechanism for many transcription factors. Post-transla-The octamer-binding transcription factor 4 (Oct4, also known as
Oct3/4) is a homeodomain transcription factor of the POU family
that is encoded by the POU5F1 gene. It plays an essential role in
the self-renewal of inner-cell-mass cells or epiblast stem cells
in vivo as well as embryonic stem cells (ESCs) in vitro, and is indis-
pensable for generating the induced pluripotent stem cells (iPSCs)
[1]. Although Oct4 is undetectable in most differentiated tissues
and cells [1], growing evidence documented its low-level expres-
sion in certain tissue stem cells [2] and stem-like cancer cells [3].
However, the exact roles and the regulation of Oct4 in those cells
remain elusive.
In contrast to the transcriptional regulation of Oct4 expression
that has been extensively studied [1,4,5], far less is known about
its post-translational regulation that emerges to be a crucialtional modiﬁcations (PTMs) refer to chemical modiﬁcations of a
protein by covalently and reversibly adding a functional group or
a protein to its speciﬁc amino acid residue(s) [6]. Thus far, over
200 types of PTMs have been identiﬁed and the most common ones
include phosphorylation, ubiquitination, sumoylation, glycosyla-
tion, acetylation, and methylation, which play essential roles in
regulating the structure, activity and localization of the proteins
and their interaction with other cellular components [6]. The
reversible PTMs are well placed to sense, relay and integrate a vari-
ety of extracellular and intracellular signals. The studies on his-
tones have exempliﬁed how combinations of PTMs can function
in concert to allow for the storage and transduction of highly spe-
ciﬁc signals to control epigenetics-based gene transcription. Such
combinatorial histone PTMs serve much like a bar code, providing
great potential for signal diversity [7]. The PTM bar code concept
has also been used to correlate speciﬁc biological behaviors of
the tumor suppressor p53 with various stimuli [8]. However,
because the sample preparation for mass spectrometric measure-
ments of the combinatorial PTM codes on a speciﬁc protein is tech-
nically demanding, only a very limited number of successful cases
have been reported so far.
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nation, sumoylation, glycosylation have been identiﬁed at multiple
residues in Oct4 present in ESCs and embryonal carcinoma cells
(ECCs) [9], in most cases only sporadic and individual sites were
reported. For instance, Lin et al. reported that the phosphorylation
of Oct4-T235 by Akt orchestrates the regulation of its stability,
subcellular localization, and transcriptional activities, which collec-
tively promotes the survival and tumorigenicity of ECCs [10]. Spelat
et al. found that the phosphorylation of Oct4-S111 by ERK1/2
enhances Oct4 degradation and distribution in cytoplasm [11].
The most in-depth PTM identiﬁcation study carried out for Oct4
so far was from Brumbaugh et al. where 14 phosphorylation sites
were collectively identiﬁed in multiple human ESC samples by
liquid chromatography mass spectrometry [12]. However, neither
a time course-dependent proﬁling of the Oct4 PTMs in response
to certain stimuli in a given cell type, nor a systematic proﬁling
and comparing of the Oct4 PTMs in different cellular contexts has
been reported. The main hurdle is likely to be the difﬁculty in
obtaining endogenous or over-expressed Oct4 proteins with sufﬁ-
cient quantity and purity for mass spectrometric analyses.
In the present study, by incubating a large quantity of highly
puriﬁed Escherichia coli-derived recombinant Oct4 proteins with
the whole lysates of a variety of human cells, we developed a
labor- and cost-effective in vitro PTMmethod for mass spectromet-
ric determination of the Oct4 PTM proﬁles in different cellular con-
texts. A number of Oct4 phosphorylation sites that were commonly
present in all the cellular contexts or speciﬁcally present in a par-
ticular cellular context were identiﬁed, indicating that Oct4 in dif-
ferent cellular environment is controlled by both common and
distinct PTM regulatory pathways. Our work indicated that such
a cell-free system-based in vitro PTM approach has the potential
to fully decipher various PTM barcodes of Oct4 in different cellular
contexts.2. Materials and methods
2.1. Antibodies and reagents
Polyclonal anti-His antibody (A00174) was from GenScript
(Piscataway, NJ, USA). Peroxidase-conjugated anti-rabbit second-
ary antibody (31460) was from Thermo Fisher Scientiﬁc (Waltham,
MA, USA). Polyclonal anti-phospho-Oct4 (Oct4-pT235) was cus-
tom-made by GenScript (order ID: 134164-1). Adenosine triphos-
phate (ATP, AB0020) was from Sangon Biotech Shanghai Co., Ltd.
(Shanghai, China). Most chemicals were from Sigma–Aldrich (St.
Louis, MO, USA).
2.2. Cell culture and transfection
NCCIT, U87, 293T and H1 cells were obtained from American
Type Culture Collection (ATCC, Rockville, MD, USA) and cultured
as described previously [10]. For transfection, 293T cells were
grown on 10 cm plates to a 30–50% conﬂuence, and transfected
with 5–10 lg of DNA per plate using GenEscort II reagent (Wise-
gen, Nanjing, China) with a ratio of 1:3 (w/v).
2.3. Plasmids
The human Oct4 construct with the 6  His tag (N terminal)
was subcloned into the EcoRI and SacI sites of the pET28a vector
using the following primers:
Forward primer, 50-ATGCGAATTCATGGCGGGACACCTGGCTTC
GG-30
Reverse primer, 50-ATGCGTCGACTCAGTTTGAATGCATGGGAG-30The Flag-Oct4-6  His portion was subcloned into the EcoRI and
XbaI sites of the pLKO.1-TRC-shOct4-Flag-Oct4 plasmid [10] using
the following primers:
Forward primer, 50-GGAATTCATGGCGGGACACCTGGCTT-30
Reverse primer, 50-CACTACTACTACTACTACCGACGACGGCGACG
GCGCGCCGTGGTTCAGTTTGAATGCATGGGAGAGC-30
2.4. Immunoblotting and immunoprecipitation
Immunoblotting and immunoprecipitation was conducted as
described previously [10].
2.5. Recombinant protein expression and puriﬁcation
The His-tagged human Oct4 construct was transformed into
Rosseta E. coli strain and the puriﬁcation procedures were as
described previously [10]. After sonication, the E. coli lysate was
centrifuged at 12,000g for 10 min at 4 C and the supernatants
were mixed with 1 ml of a 50% (w/v) slurry of Ni–NTA beads
(QIAGEN, Germantown, MD, USA), and incubated at 4 C on a
rotary shaker for 2 h. The mixture was then centrifuged at 800g
for 2 min and the supernatant was discarded. The beads were then
washed with lysis buffer containing 50 mM imidazole. The pro-
teins binding on Ni–NTA beads were used for subsequent in vitro
PTM assay.
2.6. Cell-free system-based in vitro PTM of recombinant Oct4 proteins
An aliquot (5 lg) of puriﬁed recombinant His-Oct4 protein
binding to the Ni–NTA beads (100 ll) was incubated with 1 mg
of the whole lysate derived from NCCIT, H1 or U87 cells at 30 C
for 1 h in 1 ml PMA buffer (50 mM Tris–HCl, pH 7.4, 50 mM KCl,
5 mM MgCl2, 0.5% NP-40, 5 mM ATP, 100 lM S-adenosyl methio-
nine, 100 lM acetyl-CoA, 1% EDTA-free protease inhibitor cocktail
and phosphatase inhibitor cocktail). The His-Oct4 conjugated
beads were sedimented by centrifugation at 800g for 2 min,
washed three times with ice-cold PMA washing buffer (50 mM
Tris–HCl, pH 7.4, 50 mM KCl, 5 mM MgCl2, 0.5% NP-40), eluted
and denatured in SDS–PAGE sample loading buffer by heating at
100 C for 5 min. Pooled samples (10–20 lg) were loaded and sep-
arated by SDS–PAGE and stained with Coomassie brilliant blue
R250. After destaining, the Oct4 bands (with a molecular weight
of 45 kDa) were excised and analyzed by mass spectrometry.
2.7. Mass spectrometric identiﬁcation of PTMs in Oct4 proteins
Oct4 samples were subjected to overnight digestion with tryp-
sin or chymotrypsin as described by Liu et al. [13]. The peptides
were extracted with acetonitrile containing 0.1% formic acid and
vacuum dried. Proteolytic peptides were reconstituted with mobile
phase A (2% acetonitrile containing 0.1% formic acid) and then sep-
arated on an on-line C18 column (75 lm inner diameter, 360 lm
outer diameter, 10 cm, 3 lm C18). Mass spectrometry analysis
was carried out on an LTQ-Orbitrap Velos mass spectrometer
(Thermo Fisher Scientiﬁc, Waltham, MA, USA) operated in data
dependent scan mode. Survey scan (m/z 375–1300) was performed
at a resolution of 60,000 followed by MS2 scans to fragment the 50
most abundant precursors with collision induced dissociation. The
activation time was set at 30 ms, the isolation width was 1.5 amu,
the normalized activation energy was 35%, and the activation q
was 0.25. Mass spectrometry raw ﬁle was searched by Proteome
Discovery version 1.3 using MASCOT search engine with percolator
against the human ref-sequence protein database (updated on 07-
04-2013). A ﬁlter of 90% peptide conﬁdence was applied according
to the Peptide-Prophet and Protein-Prophet parsimony algorithms.
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manual inspection and validation using the original tandem mass
spectra acquired in proﬁle mode using Xcalibur software.
3. Results
3.1. Bacterially-expressed Oct4 proteins can be phosphorylated in vitro
in a human cell-free system
Our general experimental strategy is summarized in Fig. 1A. To
test if bacterially-expressed recombinant Oct4 proteins have the
potential to be phosphorylated by a human cell-free system, we
incubated the E. coli-derived 6  His-tagged Oct4 proteins with
the NCCIT whole cell lysates for varying periods, pulled down the
reacted His-Oct4 proteins, subjected them to SDS–PAGE, and deter-
mined the levels of a site-speciﬁc phosphor Oct4 (Oct4-pT235)
using immunoblotting (Fig. 1B). The Oct4-pT235 band was absent
in His-Oct4 samples without NCCIT lysate incubation, but
appeared at 10 min and became saturated at 60 min after incuba-
tion, suggesting that the bacterially-expressed Oct4 proteins can
be phosphorylated by enzymes present in NCCIT cell lysates. In a
parallel experiment in which Flag-Oct4-His was over-expressed
in 1  107 of 293T cells and afﬁnity puriﬁed using the Ni–NTA
beads, only a small quantity (1 lg) of Flag-Oct4-His proteins
were obtained which was not sufﬁcient for mass spectrometric
analysis of the PTM proﬁles (Fig. 1C), highlighting the technical dif-
ﬁculties of the routine approach and the advantages of the in vitro
PTM approach we developed in this study.
3.2. Comparing phosphorylation proﬁles of Oct4 in different cellular
contexts
Next, we determined by mass spectrometry the phosphoryla-
tion proﬁles of Oct4 incubated with the whole cell lysates of H1,A B
C
Fig. 1. Cell-free system-based in vitro PTM approach. (A) Schematic representation of the
Ni–NTA beads (20 ll) was incubated with 0.2 mg of NCCIT whole cell lysate in 1 ml
immunoblotted with the indicated antibodies or stained with the Coomassie brilliant bl
(with non-transfected cells being the negative control, Ctr) and the over-expressed Fla
subjected to SDS–PAGE, immunoblotted with anti-His or stained with the Coomassie brNCCIT, or U87 representing human ESCs, ECCs or differentiated
cancer cells, respectively. In the absence of in vitro PTM, E. coli-
derived His-Oct4 proteins only contained one phosphor site
(S303) indicative of a low level of basal phosphorylation in bacte-
rial context. In sharp contrast, 15, 16 or 11 phosphor sites were
identiﬁed when the His-Oct4 proteins were exposed to the H1,
NCCIT, or U87 cellular context, respectively. 6 phosphorylation
sites were present in all cellular contexts, 7 sites were shared
between H1 and NCCIT, 2 sites shared between H1 and U87, and
2 sites shared between NCCIT and U87 (Table 1, Fig. 2A). Intrigu-
ingly, T331 was a unique phosphorylation site in NCCIT cells, and
phosphor T322 was only identiﬁed in U87 cells (Table 1).
Collectively, we identiﬁed 19 phosphorylation sites spanning
the whole Oct4 sequence (Figs. 2B and 3A), of which 7 have been
reported previously and 12 are novel (including 8 serine sites
and 4 threonine sites), comparing to 17 phosphorylation sites
listed at the PhosphoSitePlus website (Table 1 and Fig. 2B). We
identiﬁed a total of 15 phosphorylation sites in Oct4 from the con-
text of human ESCs (H1 cells), of which 5 overlapped with the 14
phosphor sites identiﬁed in H1 cells by Brumbaugh et al. [12]
(Table 1 and Fig. 2C).3.3. Characterization of Oct4 phosphorylation sites
We further compared all the experimentally identiﬁed Oct4
phosphorylation sites thus far (both by others and us) with those
bioinformatically predicted by the NetPhos 2.0 Server. Among the
total of 21 predicted sites, 15 were conﬁrmed by the experiments.
Remarkably, 13 out of the 14 predicted phosphor-serine sites, and
2 out of the 3 predicted phosphor-threonine sites were validated
experimentally, while none of the 4 predicted phosphor-tyrosine
sites were identiﬁed in the real experiments. The other 8 phos-
phor-threonine sites were not predicted but experimentally identi-
ﬁed (Supplementary Table 1 and Fig. 2D).general strategy. (B) 1 lg of puriﬁed E. coli-derived His-Oct4 protein binding to the
PMA buffer at 30 C for varying periods. Samples were subjected to SDS–PAGE,
ue R250. (C) The Flag-Oct4-His construct was transfected into 1  107 of 293T cells
g-Oct4-His proteins were afﬁnity puriﬁed using the Ni–NTA beads. Samples were
illiant blue R250.
Table 1
Comparison of Oct4 phosphorylation sites identiﬁed in this study and from other sources.
Type Site Phospho-SitePlusa H1 lysateb NCCIT lysateb U87 lysateb 293T expression Brumbaugh et al. study [12]
Ser S12 S12 S12 S12 – – –
S55 – S55 S55 – – –
S93 S93 – – – – S93
S105 S105 – – – – S105
S107 S107 – – – – S107
S111 S111 – – – – S111
S136 – – S136 S136 – –
S180 S180 – – – – –
S193 – S193 S193 S193 – –
S236 S236 S236 S236 – S236 S236
S288 S288 – – – – S288
S289 S289 S289 S289 – – S289
S290 – S290 S290 S290 – –
S303 – S303 S303 S303 – –
S306 – S306 S306 – –
S327 – S327 S327 S327 – –
S349 – S349 S349 – –
S355 S355 S355 S355 S355 – S355
S359 S359 – S359 S359 – S359
Thr T92 T92 – – – – T92
T116 T116 – – – – T116
T118 T118 – – – – T118
T163 T163 – – – – –
T225 – T225 T225 T225 – –
T235 T235 T235 T235 – – T235
T322 – – – T322 – –
T331 – – T331 – – –
T351 – T351 T351 – – –
T352 T352 T352 – T352 – T352
293T expression – data from this study where Oct4 was ectopically over-expressed in 293T cells and afﬁnity puriﬁed for mass spectrometric analysis.
Phosphor S303 (highlighted in bold) was detected in E. coli-expressed His-Oct4 proteins without in vitro PTM.
a Data from Cell Signaling Technology Company database ‘‘PhosphoSitePlus’’.
b Data from this study where E. coli-expressed His-Oct4 proteins were incubated with whole cell lysates of H1, NCCIT or U87 cells in an in vitro PTM assay followed by mass
spectrometric analysis.
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6
7
22
1
0 1
B
CST-PhosphoSitePlus (17 sites)
This study (19 sites)
S12
S55
S236
S193
S290
S289
S306
S303
S327
S349
T225
T235
T352
T351
S359
7
12
S136
S355
T331
T322
10
Brumbaugh et al.(H1, 14 sites)
C
This study (H1,15 sites)
S12
S55
S236S193
S290 S289
S306
S303
S327
S349
T225
T235
T352
T351
S93
S105
S111
S107
S288
S355
T92
T116
T118
5
910
D
Bioinformatic prediction (21 sites)
Experimental determination (29 sites)
Ser 13
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Fig. 2. Overview and various comparisons of the Oct4 phosphorylation sites. (A) A comparison of Oct4 phosphorylation sites in different cellular contexts. The overlapping
phosphor sites indicate common regulatory mechanisms while the non-overlapping sites indicate unique regulatory mechanisms. (B) A comparison between the phosphor
sites identiﬁed in this study with those reported in the CST-PhosphoSitePlus. (C) A comparison between the phosphor sites in H1 cells identiﬁed in this study with those
reported by Brumbaugh et al. (D) A comparison of the proportions of the three phosphorylated residues (Ser: serine, Thr: threonine, Tyr: tyrosine) between experimental
determinations and bioinformatic predictions.
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phosphorylation sites at these domains may play an important role
in regulating the interaction between Oct4 and its target genes. We
identiﬁed 1 phosphor-serine (S193) at the POUS domain, 1 phos-
phor-threonine (T235) and 1 phosphor-serine (S236) at the POUHdomain (Fig. 3A). Hydropathy plot showed that the whole region
of the human Oct4 POU domains spanning AA138 to AA289 (corre-
sponding to mouse Oct4 AA131 to AA282) was overall hydrophobic
but T235 and S236 were located at a highly hydrophilic area right
next to the nuclear localization signal (NLS) sequence (Fig. 3B) and
AB
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S1
36
S1
93
T2
25
T2
35
S2
36
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N C
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Fig. 3. Characterization of Oct4 phosphorylation sites. (A) All Oct4 phosphorylation sites collectively identiﬁed from three cellular contexts in this study. Phosphor-S303
(highlighted in pink) is the only phosphor site also identiﬁed in recombinant Oct4 proteins without in vitro PTM, indicating a low level of basal phosphorylation in bacterially-
expressed Oct4. (B) Hydropathy plot for all the residues of Oct4. The phosphorylated sites at the POU domains are marked in red or blue. (C) Structural modeling showing
close proximity of Oct4-T235 and -S236 to one of the target DNA strands. (D) Amino acid sequence alignment showing high conservativity of the phosphorylated sites at the
POU domains.
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phorylation of these two residues is likely to have profound effect
on the Oct4-DNA interaction. Amino acid sequence alignment fur-
ther showed that all the phosphor-sites at the POU domains were
highly conserved across multiple species, implicating important
functional roles (Fig. 3D).
3.4. Regulatory network of Oct4 phosphorylation
To explore the regulatory mechanisms for Oct4 phosphoryla-
tion, we searched for kinases and phosphatases from Oct4 binding
partners reported in the literature and predicted by the NetPhosK
1.0 Server, and attempted to build connections between those
phosphorylation enzymes and all individual phosphor sites in
Oct4. As shown in Fig. 4A, only a few connections have been
established so far. For instance, Oct4-T235 was reported to be
phosphorylated by Akt/PKB [10,15], Oct4-S236 (equivalent to
mouse Oct4-S229) was phosphorylated by PKA [16], and a total
of 5 sites (S111, S236, S289, S355 and T118) were phosphorylatedby Erk1/2 or p38/MAPK [11,12] (Fig. 4A). Thus, Erk1/2 or p38/
MAPK can phosphorylate multiple sites, either Ser or Thr, and the
same Oct4-S236 site could be phosphorylated by either Erk1/2 or
PKA, suggestive of cross-talk at multiple sites via different signal-
ing pathways.
From the Oct4 binding partners reported in multiple studies
[17–19], we found kinases and phosphatases regulating a variety
of important cellular processes, such as cell cycle progression
[20], cytoskeleton regulation, signaling pathways mediated by
PKA [16], PI3K/Akt [10,15], MAPK8/JNK, p53, MAPK/ERK [12] and
estrogen-related receptors (Fig. 4B). This indicated that Oct4 can
be regulated bymany signaling pathways tomake the cell fate deci-
sions in response to various extracellular and intracellular cues.
4. Discussion
In this study, we developed a cell-free system-based in vitro
PTM approach to accommodate the identiﬁcation of phosphoryla-
tion sites in Oct4 exposed to various cellular contexts. The main
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Fig. 4. Regulatory network of Oct4 phosphorylation. (A) The protein kinases and their corresponding phosphor sites in Oct4 that have been reported in the literature. (B)
Signaling pathways and binding partners that could potentially regulate Oct4 phosphorylation proﬁles.
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expressed Oct4 protein, it offers sufﬁcient quantity and quality of
the target protein for mass spectrometric analysis of the PTM
proﬁles. It overcomes the main limitations for obtaining enough
target proteins: a high afﬁnity antibody to immunoprecipitate
(IP) sufﬁcient endogenous target proteins, or a highly efﬁcient gene
delivery system to allow ectopic expression of target proteins in
certain hard-to-transfect cells. Second, it is highly cost-effective,
saving considerable costs for cell cultures, transfection reagents,
antibodies, and the beads for IP or pull-down. For example,
compared to the Brumbaugh et al. study where approximately
1  108 H1 cells were used for each mass spectrometric measure-
ment, only 1 mg of the H1 whole cell lysates (equivalent to
5  106 H1 cells) were required for each measurement in our
experimental system. Third, it offers high ﬂexibility of choosing
the cell types and cell statuses for investigation, and can examine
hard-to-transfect primary cells, or even hard-to-obtain clinical tis-
sue samples. Fourth, it is a tractable system with relatively high
efﬁciency and reproducibility. Given all these advantages, our sys-
tem would allow for a time-dependent proﬁling of the PTMs in
response to certain stimuli in a given cell type, or a systematic pro-
ﬁling and comparing of PTMs in different cellular contexts.
Inevitably, there are a number of uncertainties and limitations
with our system. For example, in intact cells, protein PTMs occur
in spatially-segregated subcellular compartments and also in a
sequential manner as a result of signaling cascades. However, in
the whole cell lysate-based cell-free system, the boundaries among
the subcellular compartments are removed, and the target proteins
are exposed to an environment that is perhaps not available in vivo.
In addition, in order to manifest the phosphor sites, phosphatase
inhibitors are usually added into the cell lysates or extracts, which
probably alters the balance between a kinase and its corresponding
phosphatase in an intact cellular environment. These raise the
possibility that some PTM sites identiﬁed with our system may
be artiﬁcially represented. It remains to be seen if such artiﬁcial
conditions may account for the non-overlapping phosphor sites
identiﬁed in our current study and by Brumbaugh et al. [12]. Apossible and partial solution might be to incubate the bacterially-
expressed target proteins with a particular subcellular fraction
(e.g., nuclear extraction for Oct4) in the absence of any phospha-
tase inhibitors. Furthermore, the basal PTMs occurred at the bacte-
rially-expressed target proteins need to be taken into account.
Although our current results showed that the basal phosphoryla-
tion level of E. coli-derived Oct4 proteins is minimal, other PTMs
may not be the same case, and therefore appropriate negative con-
trols would be important for proper interpretation of the mass
spectrometric results.
Cellular contexts can critically affect the PTM proﬁles and hence
the behaviors and functions of the target proteins. For instance,
phosphorylation of Oct4-T235 by Akt in NCCIT cells stabilized
the Oct4 protein and promoted self-renewal and pluripotency
[10], while the identical phosphorylation in HEK293A cells pro-
moted the degradation of Oct4 [15]. A more thorough PTM proﬁl-
ing may offer important clues to this discrepancy. Our current
study identiﬁed a number of phosphor sites commonly or differen-
tially regulated in different cellular contexts that could form spe-
ciﬁc PTM barcodes. Thus, the 6 phosphor sites commonly present
in all three cellular contexts may correspond to fundamental regu-
latory pathways such as MAPK/ERK, PI3K/Akt and cell cycle path-
ways. The 7 phosphor sites shared between H1 and NCCIT cells
may constitute a self-renewal and pluripotency PTM barcode. Like-
wise, the 2 sites shared by NCCIT and U87 cells (S136 and S359)
might be part of the carcinogenesis PTM barcode. Furthermore,
Oct4-T331 was a unique phosphor site in NCCIT cells that may
serve as a biomarker for testicular germ cell tumors [21], and
Oct4-T322 that was uniquely phosphorylated in U87 cellular con-
text might be associated with the formation of glioblastoma stem-
like cancer cells [22]. Future work is required to examine the above
assumptions. Although we only focused on phosphorylation of
Oct4 in this study, the experimental system developed here may
be adapted to other PTMs and other proteins if individualized opti-
mization and appropriate controls can be applied. Such system is
well suited to deciphering the PTM barcodes or the PTM atlas of
most target proteins exposed to various cellular contexts.
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